After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Zai Lab Limited ADR is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Zai Lab Limited ADR is $1.98B. A total of 1.84 million shares were traded on the day, compared to an average of 651.45K shares.
In the most recent transaction, Reinhart Harald sold 2,105 shares of ZLAB for 15.67 per share on Apr 04 ’24. After the transaction, the insider now owns 51,800 company shares. In a previous transaction on Apr 04 ’24, Smiley Joshua L sold 1,988 shares at 15.67 per share. ZLAB shares that the insider owns now total 28,684.
Among the insiders who sold shares, Amado Rafael disposed of 1,952 shares on Apr 04 ’24 at a per-share price of $15.67. This resulted in the insider holding 23,532 shares of ZLAB after the transaction. In another insider transaction, Edmondson Frazor Titus III sold 1,244 shares at $15.67 per share on Apr 04 ’24. Company shares held by the Chief Legal Officer now total 26,408.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ZLAB has a high of $39.50 and a low of $13.48.
As of this writing, ZLAB has an earnings estimate of -$0.86 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$0.75 per share and a lower estimate of -$1.06. The company reported an EPS of -$1.25 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ZLAB’s latest balance sheet shows that the firm has $1.41B in Cash & Short Term Investments as of fiscal 2021. There were $15.54M in debt and $192.90M in liabilities at the time. Its Book Value Per Share was $7.83, while its Total Shareholder’s Equity was $1.38B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZLAB is Buy with a score of 5.00.
